- Evaluation of a tyrosine kinase peptide microarray for tyrosine kinase inhibitor therapy selection in cancer
-
Labots M, Gotink KJ, Dekker H, Azijli K, van der Mijn JC, Huijts CM, Piersma SR, Jiménez C, Verheul HM
- KMID: 2367555
- Exp Mol Med.
- 2016 Dec;48(12):e279.
- doi: 10.1038/emm.2016.114
Personalized cancer medicine aims to accurately predict the response of individual patients to targeted therapies, including tyrosine kinase inhibitors (TKIs). Clinical implementation of this concept requires a robust selection tool.... -
- CITED
-
- Close
- SHARE
-
- Close
